229 related articles for article (PubMed ID: 1506683)
21. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a new minor lymphocyte stimulatory system. I. Cluster of self antigens recognized by "I-E-reactive" V beta s, V beta 5, V beta 11, and V beta 12 T cell receptors for antigen.
Abe R; Kanagawa O; Sheard MA; Malissen B; Foo-Phillips M
J Immunol; 1991 Aug; 147(3):739-49. PubMed ID: 1713604
[TBL] [Abstract][Full Text] [Related]
23. Production of minor lymphocyte stimulatory-1a antigen from activated CD4+ or CD8+ T cells.
Arase-Fukushi N; Arase H; Ogasawara K; Good RA; Onoé K
J Immunol; 1993 Nov; 151(9):4445-54. PubMed ID: 8104995
[TBL] [Abstract][Full Text] [Related]
24. Expression of Lyb-5 and Mls determinants by Peyer's patch B lymphocytes of X-linked immunodeficient mice.
Eldridge JH; Yaffe LJ; Ryan JJ; Kiyono H; Scher I; McGhee JR
J Immunol; 1984 Nov; 133(5):2308-11. PubMed ID: 6332843
[TBL] [Abstract][Full Text] [Related]
25. Induction of neonatal tolerance to the Mls-1a self-super-antigen. Time kinetics and MHC restriction.
Dannecker G; Mecheri S; Hoffmann MK
J Immunol; 1991 Nov; 147(9):2833-8. PubMed ID: 1833458
[TBL] [Abstract][Full Text] [Related]
26. Genetic analysis of the presentation of minor lymphocyte stimulating determinants. I. Combined importance of MHC and non-MHC influences.
Ryan JJ; Mond JJ; Finkelman FD
J Immunol; 1988 Aug; 141(4):1063-73. PubMed ID: 3135319
[TBL] [Abstract][Full Text] [Related]
27. T cell recognition of Mlsc,x determinants.
Abromson-Leeman SR; Laning JC; Dorf ME
J Immunol; 1988 Mar; 140(6):1726-31. PubMed ID: 3126235
[TBL] [Abstract][Full Text] [Related]
28. Analysis of T cell receptor V beta gene usage in primary mixed lymphocyte reactions: evidence for directive usage by different antigen-presenting cells and Mls-like determinants on T cell blasts.
Larsson-Sciard EL; Spetz-Hagberg AL; Casrouge A; Kourilsky P
Eur J Immunol; 1990 Jun; 20(6):1223-9. PubMed ID: 2142455
[TBL] [Abstract][Full Text] [Related]
29. Clonal deletion of self-Mls-reactive thymocytes at the early stage in H-2-compatible but Mls-disparate radiation chimeras.
Ogimoto M; Yoshikai Y; Matsuzaki G; Ohga S; Matsumoto K; Nomoto K
Immunology; 1990 Mar; 69(3):482-6. PubMed ID: 2312170
[TBL] [Abstract][Full Text] [Related]
30. Clonal deletion of self-reactive T cells at the early stage of T cell development in thymus of radiation bone marrow chimeras.
Matsuzaki G; Yoshikai Y; Ogimoto M; Kishihara K; Nomoto K
J Immunol; 1990 Jul; 145(1):46-51. PubMed ID: 2141619
[TBL] [Abstract][Full Text] [Related]
31. B lymphocyte production in the bone marrow of mice with X-linked immunodeficiency (xid).
Reid GK; Osmond DG
J Immunol; 1985 Oct; 135(4):2299-302. PubMed ID: 3875649
[TBL] [Abstract][Full Text] [Related]
32. Clonal analysis of the Mls system. A reappraisal of polymorphism and allelism among Mlsa, Mlsc, and Mlsd.
Abe R; Ryan JJ; Hodes RJ
J Exp Med; 1987 Apr; 165(4):1113-29. PubMed ID: 2435833
[TBL] [Abstract][Full Text] [Related]
33. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
Maeda T; Eto M; Lin T; Nishimura Y; Kong YY; Nomoto K; Nomoto K
J Immunol; 1994 Nov; 153(9):4311-20. PubMed ID: 7930630
[TBL] [Abstract][Full Text] [Related]
34. Studies on non-H-2-linked lymphocyte-activating determinants. II. Nonexpression of Mls determinants in a mouse strain with an X-linked B lymphocyte immune defect.
Ahmed A; Scher I
J Immunol; 1976 Nov; 117(5 Pt.2):1922-6. PubMed ID: 62796
[TBL] [Abstract][Full Text] [Related]
35. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
[TBL] [Abstract][Full Text] [Related]
36. Population movement and fate of autoreactive V beta 6+ T cells in Mls-1a mice.
Hosono M; Ideyama S; Gyotoku J; Katsura Y
Immunology; 1993 Jul; 79(3):391-7. PubMed ID: 8406567
[TBL] [Abstract][Full Text] [Related]
37. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
38. Evidence for defects in accessory and T cell subsets in mice expressing the xid defect.
Clayberger C; DeKruyff RH; Fay R; Huber B; Cantor H
J Mol Cell Immunol; 1985; 2(2):61-9. PubMed ID: 3916931
[TBL] [Abstract][Full Text] [Related]
39. Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease.
Holländer GA; Widmer B; Burakoff SJ
J Immunol; 1994 Feb; 152(4):1609-17. PubMed ID: 7907102
[TBL] [Abstract][Full Text] [Related]
40. Immunoregulation in the Peyer's patch microenvironment. Cellular basis for the enhanced responses by the B cells of X-linked immunodeficient CBA/N mice.
Eldridge JH; Beagley KW; McGhee JR
J Immunol; 1987 Oct; 139(7):2255-62. PubMed ID: 2958543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
